{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:09:42Z","timestamp":1789182582624,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1748-717x-7-212","type":"journal-article","created":{"date-parts":[[2012,12,15]],"date-time":"2012-12-15T02:14:20Z","timestamp":1355537660000},"source":"Crossref","is-referenced-by-count":36,"title":["5-FU-induced cardiac toxicity - an underestimated problem in radiooncology?"],"prefix":"10.1186","volume":"7","author":[{"given":"Felix","family":"Steger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias G","family":"Hautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"K\u00f6lbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,15]]},"reference":[{"key":"712_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(75)91270-2","volume":"1","author":"RG Dent","year":"1975","unstructured":"Dent RG, McColl I: Letter: 5-Fluorouracil and angina. Lancet 1975, 1: 347-348.","journal-title":"Lancet"},{"key":"712_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(77)90339-7","volume":"2","author":"DL Stevenson","year":"1977","unstructured":"Stevenson DL, Mikhailidis DP, Gillett DS: Cardiotoxicity of 5-fluorouracil. Lancet 1977, 2: 406-407.","journal-title":"Lancet"},{"key":"712_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5694\/j.1326-5377.1994.tb127384.x","volume":"161","author":"SA McLachlan","year":"1994","unstructured":"McLachlan SA, Millward MJ, Toner GC, Guiney MJ, Bishop JF: The spectrum of 5-fluorouracil cardiotoxicity. Med J Aust 1994, 161: 207-209.","journal-title":"Med J Aust"},{"key":"712_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/030089168206800609","volume":"68","author":"R Labianca","year":"1982","unstructured":"Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G: Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 1982, 68: 505-510.","journal-title":"Tumori"},{"key":"712_CR5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1989.7.4.509","volume":"7","author":"S Rezkalla","year":"1989","unstructured":"Rezkalla S, Kloner RA, Ensley J, et al.: Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989, 7: 509-514.","journal-title":"J Clin Oncol"},{"key":"712_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1517\/14740330902733961","volume":"8","author":"M Saif","year":"2009","unstructured":"Saif M, Shah M, Shah A: Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf 2009, 8: 191-202. 10.1517\/14740330902733961","journal-title":"Expert Opin Drug Saf"},{"key":"712_CR7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.1992.10.11.1795","volume":"10","author":"M de Forni","year":"1992","unstructured":"de Forni M, Malet-Martino MC, Jaillais P, et al.: Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 1992, 10: 1795-1801.","journal-title":"J Clin Oncol"},{"key":"712_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000227226","volume":"50","author":"SS Akhtar","year":"1993","unstructured":"Akhtar SS, Salim KP, Bano ZA: Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study. Oncology 1993, 50: 441-444. 10.1159\/000227226","journal-title":"Oncology"},{"key":"712_CR9","first-page":"205","volume":"10","author":"N Tsavaris","year":"2005","unstructured":"Tsavaris N, Kosmas C, Vadiaka M, et al.: 5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study. J BUON 2005, 10: 205-211.","journal-title":"J BUON"},{"key":"712_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","volume":"134","author":"C Kosmas","year":"2008","unstructured":"Kosmas C, Kallistratos M, Kopterides P, et al.: Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res Clin Oncol 2008, 134: 75-82.","journal-title":"J Cancer Res Clin Oncol"},{"key":"712_CR11","first-page":"805","volume":"10","author":"M Cwikiel","year":"1996","unstructured":"Cwikiel M, Eskilsson J, Wieslander JB, Stjernquist U, Albertsson M: The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits. Scanning Microsc 1996, 10: 805-818. discussion 819","journal-title":"Scanning Microsc"},{"key":"712_CR12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/106002809402800314","volume":"28","author":"AJ Anand","year":"1994","unstructured":"Anand AJ: Fluorouracil cardiotoxicity. Ann Pharmacother 1994, 28: 374-378.","journal-title":"Ann Pharmacother"},{"key":"712_CR13","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/0277-5379(88)90062-4","volume":"24","author":"A Thyss","year":"1988","unstructured":"Thyss A, Milano G, Schneider M, Demard F: Circulating drug levels in patients presenting cardiotoxicity to 5-FU. Eur J Cancer Clin Oncol 1988, 24: 1675-1676. 10.1016\/0277-5379(88)90062-4","journal-title":"Eur J Cancer Clin Oncol"},{"key":"712_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.bjc.6690098","volume":"79","author":"G Milano","year":"1999","unstructured":"Milano G, Etienne MC, Pierrefite V, Barberi-Heyob M, Deporte-Fety R, Ren\u00e9e N: Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity. Br J Cancer 1999, 79: 627-630. 10.1038\/sj.bjc.6690098","journal-title":"Br J Cancer"},{"key":"712_CR15","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/sj.bjc.6600967","volume":"88","author":"G Cianci","year":"2003","unstructured":"Cianci G, Morelli MF, Cannita K, et al.: Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity. Br J Cancer 2003, 88: 1507-1509. 10.1038\/sj.bjc.6600967","journal-title":"Br J Cancer"},{"key":"712_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00000441-198710000-00004","volume":"294","author":"B Patel","year":"1987","unstructured":"Patel B, Kloner RA, Ensley J, Al-Sarraf M, Kish J, Wynne J: 5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators. Am J Med Sci 1987, 294: 238-243. 10.1097\/00000441-198710000-00004","journal-title":"Am J Med Sci"},{"key":"712_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3109\/02841869009091790","volume":"29","author":"J Eskilsson","year":"1990","unstructured":"Eskilsson J, Albertsson M: Failure of preventing 5-fluorouracil cardiotoxicity by prophylactic treatment with verapamil. Acta Oncol 1990, 29: 1001-1003. 10.3109\/02841869009091790","journal-title":"Acta Oncol"},{"key":"712_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/annonc\/mdf108","volume":"13","author":"E van Cutsem","year":"2002","unstructured":"van Cutsem E, Hoff PM, Blum JL, Abt M, Osterwalder B: Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. Ann Oncol 2002, 13: 484-485. 10.1093\/annonc\/mdf108","journal-title":"Ann Oncol"},{"key":"712_CR19","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.ejca.2005.03.027","volume":"41","author":"M Ng","year":"2005","unstructured":"Ng M, Cunningham D, Norman AR: The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC). Eur J Cancer 2005, 41: 1542-1546. 10.1016\/j.ejca.2005.03.027","journal-title":"Eur J Cancer"},{"key":"712_CR20","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1200\/JCO.2009.27.3953","volume":"28","author":"SA Jensen","year":"2010","unstructured":"Jensen SA, Hasbak P, Mortensen J, Sorensen JB: Fluorouracil Induces Myocardial Ischemia With Increases of Plasma Brain Natriuretic Peptide and Lactic Acid but Without Dysfunction of Left Ventricle. J Clin Oncol 2010, 28: 5280-5286. 10.1200\/JCO.2009.27.3953","journal-title":"J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-7-212\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T23:25:32Z","timestamp":1562455532000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-212","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"212"}}